Antibe Therapeutics Inc ATE-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 06/24/22 EDT
0.65quote price arrow up+0.04 (+6.56%)
Volume
7,900
52 week range
0.60 - 4.10
Loading...
  • Open0.61
  • Day High0.65
  • Day Low0.61
  • Prev Close0.61
  • 52 Week High4.10
  • 52 Week High Date07/06/21
  • 52 Week Low0.60
  • 52 Week Low Date06/23/22

Key Stats

  • Market Cap26.14M
  • Shares Out51.87M
  • 10 Day Average Volume30,789.08
  • Dividend-
  • Dividend Yield-
  • Beta0.24
  • YTD % Change-1.52

KEY STATS

  • Open0.61
  • Day High0.65
  • Day Low0.61
  • Prev Close0.61
  • 52 Week High4.10
  • 52 Week High Date07/06/21
  • 52 Week Low0.60
  • 52 Week Low Date06/23/22
  • Market Cap26.14M
  • Shares Out51.87M
  • 10 Day Average Volume30,789.08
  • Dividend-
  • Dividend Yield-
  • Beta0.24
  • YTD % Change-1.52

RATIOS/PROFITABILITY

  • EPS (TTM)-0.53
  • P/E (TTM)-1.22
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Antibe Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Antibe Therapeutics Inc. is a commercial-stage pharmaceutical company. The Company is focused on pain, inflammation, and regenerative medicine. The Company’s products pipeline includes Otenaproxesul, ATB-352, and ATB-340. Otenaproxesul is a novel anti-inflammatory drug that releases hydrogen sulfide and combines hydrogen sulfide with naproxen, non-steroidal, anti-inflammatory drug. ATB-352 is a hydrogen sulfide-releasing derivative of ketoprofen. ATB-340 is a...
Walter Macnee
Vice Chairman of the Board
John Wallace Ph.D.
Vice Chairman of the Board
Robert Hoffman CPA
Independent Chairman of the Board
Daniel Legault J.D.
President, Chief Executive Officer, Secretary, Director
Alain Wilson
Chief Financial Officer
Scott Curtis
Executive Vice President
Address
15 Prince Arthur Avenue
Toronto, ON
M5R 1B2
Canada

Top Peers

SYMBOLLASTCHG%CHG
AEZS
Aeterna Zentaris Inc
0.1887-0.0032-1.6675%
EDSA
Edesa Biotech Inc
1.63-0.04-2.40%
PMN
ProMIS Neurosciences Inc
0.13+0.01+8.33%
CWBR
CohBar Inc
0.1759-0.0162-8.4331%
LMNL
Liminal BioSciences Inc
0.4566+0.0056+1.24%